Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Sudarshan R. Iyer(Oregon Health & Science University), Monika A. Davare(Oregon Health & Science University)
Cited by 13
Related Papers
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung Cancer
|Clinical Cancer Research|2020|381
ROS1-dependent cancers — biology, diagnostics and therapeutics
|Nature Reviews Clinical Oncology|2020|288
The A-kinase Anchor Protein MAP2B and cAMP-dependent Protein Kinase Are Associated with Class C L-type Calcium Channels in Neurons
|Journal of Biological Chemistry|1999|146
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1
Novel insight into mechanisms of ROS1 catalytic activation via loss of the extracellular domain
|Scientific Reports|2024|0